02-Dec-15 The Chinese government wants to privatize 20% of the country’s hospitals by 2020, and Memphis-based Methodist Healthcare wants to be a key component in that mission. Methodist’s strategic partnership with China-based healthcare management group Silver Mountain Capital is the company's latest move into China, in which the two organisations are developing a hospital in Shanghai. [image: Ken West]
Read More
09-Dec-15 Sanofi Pasteur has announced that the Mexican authorities have granted marketing authorization to Dengvaxia®, making it the first vaccine to be licensed in the world for the prevention of dengue. [image: See And Say]
Read More
01-Dec-15 When in May-15 Prime Minister Dmitry Medvedev tasked the government with creating a program of pharmaceutical import substitution, foreign companies were worried. Today, 60% of the drugs approved by the Russian government are produced domestically. Under the new policy, this share should increase to 90% by 2018. [image: Getty Images]
Read More
27-Nov-15 The Drug Administration of Vietnam (DAVN) launched online public services 'Level 4' in Nov-15, to help pharmaceutical firms register drug and medicine prices. The system enables companies to submit documents, pay fees, check the progress of document processing, and receive results online, from the beginning of 2016. [image: VNA]
Read More
27-Nov-15 Beritasatu Media, part of Indonesian conglomerate Lippo Group, is developing a mobile app called 1Health that will allow users to consult with doctors remotely. “1Health is a portal to educate people on health issues but… we want to offer services where people can consult doctors with an appointment or through video conference,” said Irwan Hartanto, COO of 1Health. [image: Beritasatu Media Holdings]
Read MoreGlobal Growth Markets is an intelligence, advisory and local execution firm helping clients identify opportunities, secure capital and grow their business.
We believe the only way to understand a market properly is on the ground. Our in-country experts, combined with AI-optimized analysis, give you a competitive advantage in over 40 markets across the Americas, EMEA and Asia-Pacific.
Our clients benefit from strategic insights, reduced risk and operational support, giving them the confidence to succeed in their global growth markets.
Value for money – real results at affordable rates
Work led by senior directors with >20 years track record
In-country presence across the Americas, EMEA and Asia-Pacific
Investor and private capital network built over decades
Proven frameworks for reliable insights and pragmatic advice
Boots on the ground supporting local execution
Find out more about our intelligence, advisory and execution services
Get in touch to discuss your growth markets needs:
Email: info@ggmkts.com
Follow us: